InvestorsHub Logo
Followers 23
Posts 2682
Boards Moderated 0
Alias Born 08/25/2010

Re: None

Tuesday, 08/18/2020 7:21:22 PM

Tuesday, August 18, 2020 7:21:22 PM

Post# of 233268
Sorry to post this... This is how our PR's should look, this coming from a very small start up.

Headline

BOLD-100 Significantly Outperforms Remdesivir Head-to-Head in SARS-CoV-2 (COVID-19) Model



https://www.bold-therapeutics.com/news-post?BOLD-100+Significantly+Outperforms+Remdesivir+Head-to-Head+in+SARS-CoV-2+%28COVID-19%29+Model

Our headline

CytoDyn Announces Clinically Significant Top-line Results from its Phase 2 Trial in Mild-to-Moderate COVID-19 Patients



https://www.cytodyn.com/newsroom/press-releases/detail/458/cytodyn-announces-clinically-significant-top-line-results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News